iTunes

Opening the iTunes Store.If iTunes doesn’t open, click the iTunes icon in your Dock or on your Windows desktop.Progress Indicator
Opening the iBooks Store.If iBooks doesn't open, click the iBooks app in your Dock.Progress Indicator
iTunes

iTunes is the world's easiest way to organize and add to your digital media collection.

We are unable to find iTunes on your computer. To download from the iTunes Store, get iTunes now.

Do you already have iTunes? Click I Have iTunes to open it now.

I Have iTunes Free Download
iTunes for Mac + PC

Mutagenic Activity of Idarubicin and Epirubicin in the Bacterium Salmonella Typhimurium.

The Texas Journal of Science 2002, August, 54, 3

This book is available for download with iBooks on your Mac or iOS device, and with iTunes on your computer. Books can be read with iBooks on your Mac or iOS device.

Description

Abstract. -- Idarubicin (structural analogue of daunomycin) and epirubicin (epimer of adriamycin) are two "second-generation" anthracyclines that are widely used in chemotherapy against leukemias and metastatic breast tumors, respectively. This study shows that using the Salmonella Mutagenicity Assay that idarubicin, like daunomycin, can induce frameshift (TA98; 16.1 fold), GC to AT (TA7004; 8.7 fold), and AT to GC base-substitution transition mutations (TA7001; 2.8 fold). Epirubicin, like adriamycin, can also induce frameshift (19.7 fold) and GC to AT transition mutations (14.6 fold) in this assay. Interestingly, epirubicin, but not adriamycin, can induce AT to GC mutations (2.9 fold) in this assay. **********

Mutagenic Activity of Idarubicin and Epirubicin in the Bacterium Salmonella Typhimurium.
View in iTunes
  • 2,99 €
  • Available on iPhone, iPad, iPod touch, and Mac.
  • Category: Engineering
  • Published: 01 August 2002
  • Publisher: Texas Academy of Science
  • Print Length: 18 Pages
  • Language: English
  • Requirements: To view this book, you must have an iOS device with iBooks 1.3.1 or later and iOS 4.3.3 or later, or a Mac with iBooks 1.0 or later and OS X 10.9 or later.

Customer Ratings

We have not received enough ratings to display an average for this book.